ACA
LMAT icon

Aptus Capital Advisors’s LeMaitre Vascular LMAT Stock Holding History

Aptus Capital Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-68,495
Closed -$7.48M – 1823
2026
Q1 		$7.48M Buy
68,495
+712
+1% +$67.9K 0.06% 267
2025
Q4 		$5.5M Buy
67,783
+291
+0.4% +$25.1K 0.04% 312
2025
Q3 		$5.91M Buy
67,492
+8,871
+15% +$792K 0.04% 301
2025
Q2 		$4.87M Buy
58,621
+5,193
+10% +$434K 0.04% 299
2025
Q1 		$4.48M Buy
+53,428
New +$4.97M 0.05% 295

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Aptus Capital Advisors's LMAT Position: Q2 2026 in Review

Aptus Capital Advisors sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 68,495 shares — an estimated $7.48M sold.

Aptus Capital Advisors first reported a position in LMAT in Q1 2025 and held it in 5 quarters. The position peaked at $7.48M in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Aptus Capital Advisors reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
  • Aptus Capital Advisors sold 68,495 LeMaitre Vascular shares in Q2 2026, an estimated $7.48M.
  • Aptus Capital Advisors first reported a position in LeMaitre Vascular in Q1 2025 and held it in 5 quarters.
  • Aptus Capital Advisors's LeMaitre Vascular position peaked at $7.48M in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.